Announcement of the State Food and Drug Administration on Revising the Instructions for Ginkgo Damo Injection

On May 21, the State Food and Drug Administration issued an announcement on revising the instructions of Ginkgo Damo injection.

If the revised content involves the label of a drug, it shall be revised together; the instructions and other content of the label shall be consistent with the original approved content.

The holder of the drug marketing authorization shall conduct in-depth research on the mechanism of new adverse reactions, take effective measures to conduct publicity and training on the use and safety issues, and immediately notify the drug dealer and user unit of the content change involving drug safety in an appropriate manner.

The provincial drug supervision and administration department shall urge the holders of the drug marketing authorization of this product in the administrative area to do the corresponding manual revision and label and manual replacement work as required, and severely investigate and punish violations of laws and regulations in accordance with the law.